Skip to main content
DHR
NYSE Life Sciences

Danaher Files for €3 Billion Senior Notes Offering

feedReported by Reuters
Sentiment info
Neutral
Importance info
8
Price
$183.81
Mkt Cap
$130.245B
52W Low
$180.03
52W High
$242.8
Market data snapshot near publication time

summarizeSummary

Danaher Corporation has filed for a four-part senior notes offering of up to €3 billion. This significant financing event, representing a material increase in the company's debt, follows the company's recent strong first-quarter earnings report and the establishment of a new $5 billion revolving credit facility. The offering will impact Danaher's capital structure and could be used for general corporate purposes, including potential acquisitions or refinancing existing debt. Traders should monitor the final terms of the offering and the stated use of proceeds for further implications.

At the time of this announcement, DHR was trading at $183.81 on NYSE in the Life Sciences sector, with a market capitalization of approximately $130.2B. The 52-week trading range was $180.03 to $242.80. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed DHR - Latest Insights

DHR
Apr 29, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
DHR
Apr 23, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
8
DHR
Apr 22, 2026, 6:03 PM EDT
Source: Reuters
Importance Score:
8
DHR
Apr 22, 2026, 4:34 PM EDT
Filing Type: FWP
Importance Score:
8
DHR
Apr 21, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
DHR
Apr 20, 2026, 5:44 PM EDT
Filing Type: 8-K
Importance Score:
7
DHR
Apr 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
DHR
Apr 17, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
DHR
Apr 17, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
DHR
Mar 25, 2026, 8:12 AM EDT
Filing Type: DEFA14A
Importance Score:
7